Recent Developments in the Russian Pharmaceutical Industry

31 May 2013
Download PDF

During the first few months of 2013, the Russian government has proposed, and in some cases adopted, new legislation that introduces a number of significant changes to the regulation of pharmaceuticals in Russia, including:

  • improved access to government procurement for manufacturers and distributors of pharmaceutical products;
  • continuation of preferences for pharmaceuticals qualifying as products of Russian or Belarusian origin; and
  • the imposition of additional restrictions on the advertisement of pharmaceuticals in Russia, including potentially an outright ban on advertising all together.